+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Early gene activation in chronic leukemic B lymphocytes induced toward a plasma cell phenotype

Early gene activation in chronic leukemic B lymphocytes induced toward a plasma cell phenotype

Blood Cells Molecules and Diseases 30(3): 277-287

Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of lymphocytes that are arrested at an intermediate stage of B lymphocyte development. CLL B lymphocytes transform (mature) to a plasmacytic phenotype with loss of CD19 and CD20 and the appearance of cytoplasmic immunoglobulin when treated in vitro with phorbol esters. We have used array hybridization technology to describe gene expression patterns for untreated and tetradecanoyl phorbol acetate (TPA)-treated CLL B cells at 5, 10, and 20 min following initial TPA exposure. Three genes, early growth response factor 1 (EGR-1), dual specificity phosphatase 2, and CD69 (early T-cell activation antigen), showed a 2.0-fold or greater increase in mRNA transcription at four or more of six time points in two studies. Upregulation of expression of these genes was confirmed by real-time polymerase chain reaction in the TPA-treated cells of four CLL patients. A progressive increase in gene expression was observed during the 20-min time course for all three genes. In addition, protein expression of EGR-1 and CD69 was increased as measured by immunofluorescence cell analysis. Several genes (PKC, n-myc, jun D, and BCL-2) previously reported as overexpressed in CLL lymphocytes were overexpressed in these studies also, but were not altered by TPA treatment. Genes for proteins whose upregulation requires hours of TPA exposure (the 4F2hc component of the L-system amino acid transporter, prohibition, and hsp60) were assessed, and their later expression contrasted with the early expression of EGR-1, dual specificity phosphatase 2, and CD69. EGR-1 encodes a zinc-finger transcription factor that is induced by pokeweed mitogen and TPA and promotes B lymphocyte maturation. The dual specificity phosphatase 2 encodes an enzyme that reverses mitogen activated protein kinase cell activation by dephosphorylation. The CD69 protein is induced by TPA in thymocytes and is a type II transmembrane signaling molecule in hematopoietic cells. These findings suggest that the products of these three genes may be central to early steps in the TPA-induced evolution of CLL B cells to a plasmacytic phenotype.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 010506879

Download citation: RISBibTeXText

PMID: 12737946

DOI: 10.1016/s1079-9796(03)00035-4

Related references

Early Gene Activation in Chronic Leukemic B Lymphocytes Exposed to Phorbol Ester. Blood 100(11): Abstract No 4280, 2002

Immunologic phenotype of lymphocytes in chronic B-cell lymphocytic leukemia. II. Studies of immunologic phenotype of peripheral blood and lymph node lymphocytes in patients with chronic lymphocytic leukemia or leukemic forms of lymphoplasmacytoid lymphoma. Acta Haematologica Polonica 23(1): 29-41, 1992

Protease activation is required for glucocorticoid-induced apoptosis in chronic lymphocytic leukemic lymphocytes. Blood 90(9): 3673-3681, 1997

Acid hydrolases in b chronic lymphocytic leukemia b cll a comparison with normal peripheral b lymphocytes and normal b cell subset with the phenotype of b leukemic cells. Leukemia Research 11(5): 429-436, 1987

GCSF induced gene activation maintains the hematopoietic stem cell phenotype of early murine embryonic E14 stem cells. 2007

Leukemic cell lysis by autologous lymphocytes in childhood acute lymphoblastic leukemia generation to cytolysis by lymphocytes activated with cultured non t non b leukemic cell lines. Acta Paediatrica Japonica 28(2): 161-170, 1986

Lenalidomide-induced upregulation of CD80 on tumor cells correlates with T-cell activation, the rapid onset of a cytokine release syndrome and leukemic cell clearance in chronic lymphocytic leukemia. Haematologica 94(9): 1266-1273, 2009

A T chronic lymphocytic leukemia with large granular lymphocytes. Phenotype and functions of leukemic cells under in vitro treatment by differentiation inducers. Cancer 59(7): 1296-1303, 1987

Early caspase activation in leukemic cells subject to etoposide-induced G2-M arrest: evidence of commitment to apoptosis rather than mitotic cell death. Clinical Cancer Research 6(9): 3756-3765, 2000

Studies on cell surface antigens of mouse leukemic and normal lymphocytes. IV. Functional studies on mouse T lymphocyte subpopulations. B. Lyt phenotype of cytotoxic T lymphocytes and their precursors in B6-Lyt-1.1 mice. Archivum Immunologiae et Therapiae Experimentalis 26(1-6): 111-116, 1978

Immunological phenotype of lymphocytes in chronic B-cell lymphocytic leukaemia: Part I. Lymphocytes B and T in CLL. Acta Haematologica Polonica 23(1): 21-27, 1992

Early plasma membrane protein changes following lectin activation of murine t lymphocytes and b lymphocytes. Federation Proceedings: Abstract, 1982

The Ig kappa 3'-enhancer triggers gene expression in early B lymphocytes but its activity is enhanced on B cell activation. International Immunology 8(10): 1561-1568, 1996

Heterogeneity of leukemic cell phenotype. II. Variants of hetero- phenotype in relation to myeloid and megakaryocytic markers of leukemia cells in acute leukemia and blast crisis of chronic myeloproliferative disorders. Gematologiia i Transfuziologiia 35(8): 15-18, 1990